We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » Devices » Research and Development

Research and Development
Research and Development RSS Feed RSS

FDA Approves HistoSonics Trial of Non-Invasive System to Destroy Kidney Tumors

February 15, 2023

The Edison System is currently under FDA review for treatment of liver tumors.

Read More

IRRAS Fluid Exchange System Shows Favorable Outcomes in Draining Intracranial Bleeds

February 14, 2023

In a postmarket study, IRRAS’s IRRAflow fluid exchange system more effectively removed blood from chronic subdural hematomas (cSDH) and reduced catheter-related infections when compared to passive drainage alone, researchers reported in the journal Operative Neurosurgery. 

Read More

Paragonix’s LUNGguard System Sees First Pediatric ‘Overnight’ Lung Transplant

February 10, 2023

aragonix Technologies’ LUNGguard donor lung preservation system recently saw its first use for a pediatric case in which donor lungs procured overnight were preserved with the system, allowing for next day transplant surgery.

Read More

AI Medical Technology’s Skin Cancer Diagnostic Tool Effective in Trial

February 8, 2023

Dermalyser, an artificial intelligence (AI) skin cancer diagnostic tool from Swedish start-up AI Medical Technology, diagnosed melanoma-suspected cutaneous lesions with high accuracy in a 240-patient clinical trial conducted at 37 primary care settings in Sweden.

Read More

Sensorion and EVEON Team Up to Deliver Gene Therapy to the Inner Ear

February 6, 2023

France-based biotech Sensorion and device developer EVEON are collaborating on a way to treat deafness by delivering gene therapy to the inner ear.

Read More

Consortium Gets EU Funding to Develop Continuous Blood Pressure Monitoring Device

February 3, 2023

Currently, “there is no clinically accepted method of continuous beat-to-beat blood pressure monitoring that patients can use outside of the hospital setting,” said the consortium’s leader. 

Read More

LifeScan’s App-Connected Blood Glucose Monitor Improves Blood Sugar Control

February 1, 2023
Diabetics using LifeScan’s Bluetooth-connected blood glucose monitor (BGM) in conjunction with a diabetes management digital app experienced better blood sugar control, lowered hyperglycemic readings, and significantly reduced mean glucose, the company reported in the Journal of Diabetes and Technology. Read More

Stroke Risk Algorithms Less Accurate for Black Patients, Study Finds

January 31, 2023

A simple method using patients’ answers to questions was the most accurate technique of predicting stroke. 

Read More

Stroke Risk Algorithms Less Accurate for Black Patients, Study Finds

January 30, 2023

Stroke-specific machine learning algorithms were no better at predicting stroke risk than self-reported risk factors and were worse in predicting stroke risk in Black patients than in White patients, according to a new study published in JAMA Network.

Read More

Study Shows AI Software Can Predict Diabetic Retinopathy

January 27, 2023
A new study published in the journal BMJ Open Ophthalmology shows that an artificial intelligence algorithm can successfully predict the future development of diabetic retinopathy (DR) in patients without current diagnosable symptoms. Read More

EU Cancer Imaging Initiative to Share Anonymous Data

January 26, 2023

The project will create a database of more than 100,000 anonymous cancer images and data, including common and rare cancers. 

Read More

Aetion Announces FDA Collaboration to Identify and Analyze Real-World Data

January 25, 2023

Healthcare analytics company Aetion has entered into a five-year collaboration with the FDA to use its Aetion Evidence Platform (AEP) to analyze novel oncology real-world data and answer questions about cancer prevention, clinical care, diagnostics and treatment.

Read More
Previous 1 2 3 4 5 6 7 8 9 … 70 71 Next

Upcoming Events

  • 04Apr

    Optimizing Quality Control Operations with Unified Quality

  • 20Apr

    Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Advamedica’s Hemostat Cleared for Severe Surgical Bleeding

  • FDA Approves Sandoz’s Citrate-Free Adalimubab Formulation

  • Wesper Next-Generation Device Cleared for Sleep Test Data Collection

  • FDA Approves First-Ever Treatment for Activated Phosphoinositide 3-Kinase Delta Syndrome

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing